
Uribegro 50mg Tablet ER
Marketer
Tas Med India Pvt Ltd
Salt Composition
Mirabegron (50mg)
Overview Uribegro 50mg Tablet ER
Extended-release Uribegro 50mg tablets alleviate overactive bladder symptoms such as urinary frequency, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your doctor's prescribed dosage and duration. It may be taken with or without food; swallow the tablet whole, avoiding crushing or chewing. Discontinue use only under medical supervision, as abrupt cessation may worsen symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infection, tachycardia, and arthralgia. Report any persistent or bothersome side effects promptly to your physician. Before starting treatment, disclose all other medications and pre-existing health conditions, including pregnancy or breastfeeding status. Individuals with hepatic or renal impairment require careful monitoring and regular physician check-ups.
Primary Ingredients of Uribegro 50mg Tablet ER
The provided text is "undefined," therefore no rephrasing is possible.
Uses of Uribegro 50mg Tablet ER
Managing symptoms associated with overactive bladder
Major Benefits of Uribegro 50mg Tablet ER:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Swallow the entire Uribegro 50mg Extended-Release tablet whole; do not chew, crush, or divide it. This medication can be taken with or without food, though consistent timing is recommended.
Common Side effects of Uribegro 50mg Tablet ER:
- Constipation
- Headache
- High blood pressure
- Nasal inflammation
- Urinary tract infection
- Fast heart rate
- Joint pain
How to use Uribegro 50mg Tablet ER:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the 50mg extended-release Uribegro tablet whole; avoid chewing, crushing, or fracturing. While consumption with or without food is permissible, consistent daily timing is recommended for optimal results.
How Uribegro 50mg Tablet ER works:
Uribegro 50mg Extended-Release tablets contain a beta-3 adrenergic agonist. This medication's mechanism of action involves stimulating bladder receptors, leading to relaxation of the bladder's musculature. The result is a reduction in urinary urgency, frequency, and incontinence.
SAFETY ADVICE
AlcoholCAUTION
Use caution when combining Uribegro 50mg Extended-Release Tablets with alcohol. Physician consultation is recommended.
PregnancyCONSULT YOUR DOCTOR
Extended-release Uribegro 50mg tablets might pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Uribegro 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Extended-release Uribegro 50mg tablets typically do not impair driving ability.
KidneyCAUTION
For individuals with severe kidney impairment, the extended-release Uribegro 50mg tablet requires careful administration. Dosage modification of Uribegro 50mg extended-release tablets may be necessary. Physician consultation is advised.
LiverCAUTION
For individuals with liver impairment, Uribegro 50mg Extended-Release tablets require careful administration; dosage modification may be necessary. Consult your physician for guidance. Uribegro 50mg Extended-Release tablets are contraindicated in patients exhibiting severe hepatic dysfunction.
What if you forget to take Uribegro 50mg Tablet ER :
Should you forget a dose of Uribegro 50mg Extended-Release Tablet, take it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Uribegro 50mg Tablet ER
| Label | Value |
|---|---|
| Chemical Type | Anilide-based Compound |
| Developing Habits | No. |
| Treatment Category | Urological Care |
| Action Class | Beta-3 agonist for bladder control |
